US20040122000A1
(en)
|
1981-01-07 |
2004-06-24 |
Vertex Pharmaceuticals Incorporated. |
Inhibitors of aspartyl protease
|
US6878728B1
(en)
|
1999-06-11 |
2005-04-12 |
Vertex Pharmaceutical Incorporated |
Inhibitors of aspartyl protease
|
US5962490A
(en)
|
1987-09-25 |
1999-10-05 |
Texas Biotechnology Corporation |
Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5736509A
(en)
*
|
1990-12-14 |
1998-04-07 |
Texas Biotechnology Corporation |
Cyclic peptide surface feature mimics of endothelin
|
ATE199109T1
(de)
*
|
1992-03-27 |
2001-02-15 |
Akiko Itai |
Verfahren zur analyse der struktur von stabilen zusammengesetzten biopolymerligandmolekuelen
|
US6046190A
(en)
*
|
1992-08-25 |
2000-04-04 |
G.D. Searle & Co. |
Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
|
US7141609B2
(en)
*
|
1992-08-25 |
2006-11-28 |
G.D. Searle & Co. |
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
US5968942A
(en)
|
1992-08-25 |
1999-10-19 |
G. D. Searle & Co. |
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
US6743929B1
(en)
*
|
1992-08-25 |
2004-06-01 |
G. D. Searle & Co. |
Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
WO1994004492A1
(en)
*
|
1992-08-25 |
1994-03-03 |
G.D. Searle & Co. |
Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
US5783701A
(en)
*
|
1992-09-08 |
1998-07-21 |
Vertex Pharmaceuticals, Incorporated |
Sulfonamide inhibitors of aspartyl protease
|
US5723490A
(en)
*
|
1992-09-08 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
THF-containing sulfonamide inhibitors of aspartyl protease
|
IS2334B
(is)
*
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
US6156768A
(en)
|
1992-10-30 |
2000-12-05 |
G. D. Searle & Co. |
Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
|
ES2196436T3
(es)
*
|
1992-10-30 |
2003-12-16 |
Searle & Co |
Acidos sulfonilalcanoilamino-hidroxietilamino-sulfamicos utiles como inhibidores de proteasas retrovirales.
|
US5846993A
(en)
*
|
1992-12-22 |
1998-12-08 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
US5484926A
(en)
*
|
1993-10-07 |
1996-01-16 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
US6376523B1
(en)
|
1994-05-20 |
2002-04-23 |
Texas Biotechnology Corporation |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
US6541498B2
(en)
|
1993-05-20 |
2003-04-01 |
Texas Biotechnology |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
US6030991A
(en)
*
|
1993-05-20 |
2000-02-29 |
Texas Biotechnology Corp. |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
US6613804B2
(en)
|
1993-05-20 |
2003-09-02 |
Encysive Pharmaceuticals, Inc. |
Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
|
US6342610B2
(en)
|
1993-05-20 |
2002-01-29 |
Texas Biotechnology Corp. |
N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5846981A
(en)
*
|
1993-05-28 |
1998-12-08 |
Gpi Nil Holdings Inc. |
Inhibitors of rotamase enzyme activity
|
US5798355A
(en)
*
|
1995-06-07 |
1998-08-25 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity
|
US7831470B1
(en)
*
|
1996-09-04 |
2010-11-09 |
Walker Digital, Llc |
Method and apparatus for facilitating electronic commerce through providing cross-benefits during a transaction
|
US5750648A
(en)
*
|
1993-08-20 |
1998-05-12 |
G.D. Searle & Co. |
Retroviral protease inhibitors and combinations thereof
|
IL110752A
(en)
*
|
1993-09-13 |
2000-07-26 |
Abbott Lab |
Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
|
US5559158A
(en)
*
|
1993-10-01 |
1996-09-24 |
Abbott Laboratories |
Pharmaceutical composition
|
US5602119A
(en)
*
|
1993-10-29 |
1997-02-11 |
Vazquez; Michael L. |
Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
|
US5527829A
(en)
*
|
1994-05-23 |
1996-06-18 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
US20030207813A1
(en)
*
|
1996-12-09 |
2003-11-06 |
G.D. Searle |
Retroviral protease inhibitor combinations
|
UA49803C2
(uk)
*
|
1994-06-03 |
2002-10-15 |
Дж.Д. Сьорль Енд Ко |
Спосіб лікування ретровірусних інфекцій
|
AU4700896A
(en)
|
1995-01-20 |
1996-08-07 |
G.D. Searle & Co. |
Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
|
US5831117A
(en)
|
1995-01-20 |
1998-11-03 |
G. D. Searle & Co. |
Method of preparing retroviral protease inhibitor intermediates
|
US5756533A
(en)
*
|
1995-03-10 |
1998-05-26 |
G.D. Searle & Co. |
Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6140505A
(en)
|
1995-03-10 |
2000-10-31 |
G. D. Searle & Co. |
Synthesis of benzo fused heterocyclic sulfonyl chlorides
|
BR9607625A
(pt)
*
|
1995-03-10 |
1999-06-15 |
Searle & Co |
Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
|
EP1188766A1
(en)
|
1995-03-10 |
2002-03-20 |
G.D. Searle & Co. |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6150556A
(en)
*
|
1995-03-10 |
2000-11-21 |
G. D. Dearle & Co. |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6861539B1
(en)
*
|
1995-03-10 |
2005-03-01 |
G. D. Searle & Co. |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6407134B1
(en)
|
1995-03-10 |
2002-06-18 |
G. D. Searle & Co. |
Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US6143788A
(en)
*
|
1995-03-10 |
2000-11-07 |
G.D. Searle & Co. |
Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors
|
US5776971A
(en)
*
|
1995-03-10 |
1998-07-07 |
G.D. Searle & Co. |
Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US7339078B2
(en)
*
|
1995-03-10 |
2008-03-04 |
G.D. Searle Llc |
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
|
US5691372A
(en)
*
|
1995-04-19 |
1997-11-25 |
Vertex Pharmaceuticals Incorporated |
Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
|
US5696135A
(en)
*
|
1995-06-07 |
1997-12-09 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
|
US5859031A
(en)
|
1995-06-07 |
1999-01-12 |
Gpi Nil Holdings, Inc. |
Small molecule inhibitors of rotamase enzyme activity
|
US6037157A
(en)
*
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
US5801197A
(en)
*
|
1995-10-31 |
1998-09-01 |
Gpi Nil Holdings, Inc. |
Rotamase enzyme activity inhibitors
|
US5767316A
(en)
|
1995-11-17 |
1998-06-16 |
Ajinomoto Co., Inc. |
Process for producing 3-amino-2-oxo-1-halogenopropane derivatives
|
US5646180A
(en)
*
|
1995-12-05 |
1997-07-08 |
Vertex Pharmaceuticals Incorporated |
Treatment of the CNS effects of HIV
|
US5914332A
(en)
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
US5977117A
(en)
|
1996-01-05 |
1999-11-02 |
Texas Biotechnology Corporation |
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
|
US6730679B1
(en)
|
1996-03-22 |
2004-05-04 |
Smithkline Beecham Corporation |
Pharmaceutical formulations
|
MY126358A
(en)
*
|
1996-03-22 |
2006-09-29 |
Glaxo Group Ltd |
Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
|
SK284244B6
(sk)
*
|
1996-03-22 |
2004-12-01 |
Glaxo Group Limited |
Farmaceutický prostriedok na liečenie HIV infekcie na orálne podanie
|
US5958905A
(en)
*
|
1996-03-26 |
1999-09-28 |
Texas Biotechnology Corporation |
Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
|
US5804585A
(en)
*
|
1996-04-15 |
1998-09-08 |
Texas Biotechnology Corporation |
Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
|
WO1997049410A1
(en)
*
|
1996-06-25 |
1997-12-31 |
Glaxo Group Limited |
Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
|
JP2000515852A
(ja)
*
|
1996-06-25 |
2000-11-28 |
グラクソ、グループ、リミテッド |
Hivの治療に使用するためのvx478、ジドブジン、ftcおよび/または3tcを含んでなる組合わせ
|
US5925759A
(en)
|
1996-09-05 |
1999-07-20 |
Agouron Pharmaceuticals, Inc. |
Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
|
US5705647A
(en)
*
|
1996-09-05 |
1998-01-06 |
Agouron Pharmaceuticals, Inc. |
Intermediates for making HIV-protease inhibitors
|
US5962725A
(en)
|
1996-09-05 |
1999-10-05 |
Agouron Pharmaceuticals, Inc. |
Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
|
US5786378A
(en)
*
|
1996-09-25 |
1998-07-28 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters
|
US5801187A
(en)
|
1996-09-25 |
1998-09-01 |
Gpi-Nil Holdings, Inc. |
Heterocyclic esters and amides
|
US6218424B1
(en)
|
1996-09-25 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Heterocyclic ketone and thioester compounds and uses
|
IN183408B
(en:Method)
*
|
1996-11-20 |
1999-12-25 |
Kuraray Co |
|
ZA9710071B
(en)
*
|
1996-11-21 |
1998-05-25 |
Abbott Lab |
Pharmaceutical composition.
|
US6232333B1
(en)
|
1996-11-21 |
2001-05-15 |
Abbott Laboratories |
Pharmaceutical composition
|
US5874449A
(en)
*
|
1996-12-31 |
1999-02-23 |
Gpi Nil Holdings, Inc. |
N-linked sulfonamides of heterocyclic thioesters
|
US6121273A
(en)
*
|
1996-12-31 |
2000-09-19 |
Gpi Nil Holdings, Inc |
N-linked sulfonamides of heterocyclic thioesters
|
US5935989A
(en)
|
1996-12-31 |
1999-08-10 |
Gpi Nil Holdings Inc. |
N-linked ureas and carbamates of heterocyclic thioesters
|
EA002401B1
(ru)
*
|
1996-12-31 |
2002-04-25 |
Джи Пи Ай Нил Холдингс, Инк. |
N-связанные мочевины и карбаматы сложных гетероциклических тиоэфиров
|
US5721256A
(en)
*
|
1997-02-12 |
1998-02-24 |
Gpi Nil Holdings, Inc. |
Method of using neurotrophic sulfonamide compounds
|
US5846979A
(en)
|
1997-02-28 |
1998-12-08 |
Gpi Nil Holdings, Inc. |
N-oxides of heterocyclic esters, amides, thioesters, and ketones
|
US6001851A
(en)
*
|
1997-03-13 |
1999-12-14 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
US5783705A
(en)
*
|
1997-04-28 |
1998-07-21 |
Texas Biotechnology Corporation |
Process of preparing alkali metal salys of hydrophobic sulfonamides
|
SG100767A1
(en)
|
1997-04-28 |
2003-12-26 |
Texas Biotechnology Corp |
Sulfonamides for treatment of endothelin-mediated disorders
|
TR199902751T2
(xx)
*
|
1997-05-08 |
2000-02-21 |
Smithkline Beecham Corporation |
Proteaz inhibit�rleri.
|
US6271244B1
(en)
|
1998-06-03 |
2001-08-07 |
Gpi Nil Holdings, Inc. |
N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
|
US6274602B1
(en)
|
1998-06-03 |
2001-08-14 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioester and ketone hair growth compositions and uses
|
US6187796B1
(en)
|
1998-06-03 |
2001-02-13 |
Gpi Nil Holdings, Inc. |
Sulfone hair growth compositions and uses
|
US5945441A
(en)
*
|
1997-06-04 |
1999-08-31 |
Gpi Nil Holdings, Inc. |
Pyrrolidine carboxylate hair revitalizing agents
|
US6187784B1
(en)
|
1998-06-03 |
2001-02-13 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivative hair growth compositions and uses
|
US20010049381A1
(en)
|
1997-06-04 |
2001-12-06 |
Gpl Nil Holdings, Inc., |
Pyrrolidine derivative hair growth compositions and uses
|
GB9712253D0
(en)
*
|
1997-06-13 |
1997-08-13 |
Glaxo Group Ltd |
Antiviral compound
|
WO1999000372A1
(en)
|
1997-06-27 |
1999-01-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonamide compounds and medicinal use thereof
|
US6084107A
(en)
*
|
1997-09-05 |
2000-07-04 |
Agouron Pharmaceuticals, Inc. |
Intermediates for making HIV-protease inhibitors
|
US6576231B2
(en)
*
|
1997-09-12 |
2003-06-10 |
Schering Ag |
Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor
|
US6180634B1
(en)
*
|
1997-11-13 |
2001-01-30 |
Merck & Co., Inc. |
Combination therapy for the treatment of AIDS
|
US6436989B1
(en)
*
|
1997-12-24 |
2002-08-20 |
Vertex Pharmaceuticals, Incorporated |
Prodrugs of aspartyl protease inhibitors
|
AU2010299A
(en)
*
|
1997-12-24 |
1999-07-19 |
Vertex Pharmaceuticals Incorporated |
Prodrugs os aspartyl protease inhibitors
|
SK9672000A3
(en)
*
|
1997-12-24 |
2001-04-09 |
Vertex Pharmaceuticals Inc Ver |
Prodrugs of aspartyl protease inhibitors
|
WO1999033795A1
(en)
*
|
1997-12-24 |
1999-07-08 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of aspartyl protease inhibitors
|
GB9805898D0
(en)
*
|
1998-03-20 |
1998-05-13 |
Glaxo Group Ltd |
Process for the sythesis of hiv protease inhibitors
|
US6251906B1
(en)
|
1998-05-15 |
2001-06-26 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
US6172087B1
(en)
|
1998-06-03 |
2001-01-09 |
Gpi Nil Holding, Inc. |
N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
|
IL140040A0
(en)
|
1998-06-03 |
2002-02-10 |
Guilford Pharm Inc |
N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
US6274617B1
(en)
|
1998-06-03 |
2001-08-14 |
Gpi Nil Holdings, Inc. |
Heterocyclic ester and amide hair growth compositions and uses
|
DE69922807T2
(de)
*
|
1998-06-19 |
2005-12-08 |
Vertex Pharmaceuticals Inc., Cambridge |
Sulfonamide als aspartyl-protease-inhibitoren
|
ES2604662T3
(es)
|
1998-06-23 |
2017-03-08 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Ensayo de acondicionamiento físico y métodos para reducir la resistencia del VIH a la terapia
|
US6538006B1
(en)
*
|
1998-07-08 |
2003-03-25 |
Pharmacia Corporation |
Retroviral protease inhibitors
|
US6713290B2
(en)
|
1998-07-24 |
2004-03-30 |
Samsung Fine Chemicals Co., Ltd. |
Process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone
|
JP3614366B2
(ja)
*
|
1998-07-24 |
2005-01-26 |
サムスン ファイン ケミカルズ カンパニー リミテッド |
光学的に純粋な(s)−3,4−ジヒドロキシ酪酸誘導体の製造方法
|
US6335348B1
(en)
|
1998-08-14 |
2002-01-01 |
Gpi Nil Holdings, Inc. |
Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
|
US6399648B1
(en)
|
1998-08-14 |
2002-06-04 |
Gpi Nil Holdings, Inc. |
N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
|
US6395758B1
(en)
|
1998-08-14 |
2002-05-28 |
Gpi Nil Holdings, Inc. |
Small molecule carbamates or ureas for vision and memory disorders
|
US6384056B1
(en)
|
1998-08-14 |
2002-05-07 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters or ketones for vision and memory disorders
|
US6218423B1
(en)
|
1998-08-14 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Pyrrolidine derivatives for vision and memory disorders
|
US6337340B1
(en)
|
1998-08-14 |
2002-01-08 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
US6333340B1
(en)
|
1998-08-14 |
2001-12-25 |
Gpi Nil Holdings, Inc. |
Small molecule sulfonamides for vision and memory disorders
|
US6339101B1
(en)
|
1998-08-14 |
2002-01-15 |
Gpi Nil Holdings, Inc. |
N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
|
US6506788B1
(en)
|
1998-08-14 |
2003-01-14 |
Gpi Nil Holdings, Inc. |
N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
|
US7338976B1
(en)
|
1998-08-14 |
2008-03-04 |
Gpi Nil Holdings, Inc. |
Heterocyclic esters or amides for vision and memory disorders
|
US6462072B1
(en)
|
1998-09-21 |
2002-10-08 |
Gpi Nil Holdings, Inc. |
Cyclic ester or amide derivatives
|
US7115584B2
(en)
*
|
1999-01-22 |
2006-10-03 |
Emory University |
HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
|
US7635690B2
(en)
*
|
1999-01-22 |
2009-12-22 |
Emory University |
HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
|
PT1159278E
(pt)
*
|
1999-02-12 |
2006-06-30 |
Vertex Pharma |
Inibidores de aspartil-protease
|
TNSN00027A1
(fr)
|
1999-02-12 |
2005-11-10 |
Vertex Pharma |
Inhibiteurs de l'aspartyle protease
|
AR031520A1
(es)
*
|
1999-06-11 |
2003-09-24 |
Vertex Pharma |
Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
|
GB9914821D0
(en)
*
|
1999-06-24 |
1999-08-25 |
Glaxo Group Ltd |
Compounds
|
WO2001025240A1
(en)
*
|
1999-10-06 |
2001-04-12 |
Tibotec Pharmaceuticals Ltd. |
HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR
|
US6548706B2
(en)
|
1999-12-23 |
2003-04-15 |
Aerojet Fine Chemicals Llc |
Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
|
EP2194038A3
(en)
|
1999-12-23 |
2010-09-01 |
Ampac Fine Chemicals LLC |
Improved preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-P-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
|
US6391919B1
(en)
|
2000-01-12 |
2002-05-21 |
Bristol-Myers Squibb Pharma Company |
Bis-amino acid sulfonamides containing substituted benzyl amines HIV protease inhibitors
|
AU1940501A
(en)
|
2000-01-19 |
2001-07-31 |
Abbott Laboratories |
Improved pharmaceutical formulations
|
PE20020276A1
(es)
*
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
US6617310B2
(en)
|
2000-07-19 |
2003-09-09 |
Bristol-Myers Squibb Pharma Company |
Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
|
SK287582B6
(sk)
|
2001-02-14 |
2011-03-04 |
Tibotec Pharmaceuticals Ltd. |
2-(Substituovaná amino)benztiazolsulfonamidová zlúčenina, spôsob jej prípravy, použitie a farmaceutická zmes s jej obsahom
|
US6756063B2
(en)
|
2001-03-29 |
2004-06-29 |
Zoltan Laboratories, Llc |
Methods and compositions for the treatment of human and animal cancers
|
NZ528954A
(en)
*
|
2001-04-09 |
2005-04-29 |
Tibotec Pharm Ltd |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
|
US6696494B2
(en)
|
2001-10-22 |
2004-02-24 |
Enanta Pharmaceuticals, Inc. |
α-hydroxyarylbutanamine inhibitors of aspartyl protease
|
CA2473231A1
(en)
*
|
2002-01-07 |
2003-08-07 |
Sequoia Pharmaceuticals |
Resistance-repellent retroviral protease inhibitors
|
JP4625637B2
(ja)
|
2002-02-22 |
2011-02-02 |
シャイア エルエルシー |
活性物質送達系及び活性物質を保護し投与する方法
|
US7157489B2
(en)
*
|
2002-03-12 |
2007-01-02 |
The Board Of Trustees Of The University Of Illinois |
HIV protease inhibitors
|
TWI332956B
(en)
|
2002-04-26 |
2010-11-11 |
Gilead Sciences Inc |
Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
|
NZ536496A
(en)
*
|
2002-05-17 |
2006-06-30 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
|
US7132568B2
(en)
*
|
2002-06-17 |
2006-11-07 |
Sunesis Pharmaceuticals, Inc. |
Aspartyl protease inhibitors
|
US7115652B2
(en)
*
|
2002-06-17 |
2006-10-03 |
Sunesis Pharmaceuticals, Inc. |
Aspartyl protease inhibitors
|
HRP20050606B1
(hr)
*
|
2002-08-14 |
2014-04-25 |
Tibotec Pharmaceuticals Ltd. |
Supstituirani oksindol sulfonamid hiv proteazni inhibitori širokog spektra
|
UY27967A1
(es)
*
|
2002-09-10 |
2004-05-31 |
Pfizer |
Acetil 2-hindroxi-1,3-diaminoalcanos
|
CA2500935C
(en)
*
|
2002-10-03 |
2014-09-23 |
New Era Biotech, Ltd. |
Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
|
WO2005092305A2
(en)
*
|
2004-03-26 |
2005-10-06 |
New Era Biotech Ltd |
Compounds for treating aids and other diseases
|
US6713639B1
(en)
|
2002-10-28 |
2004-03-30 |
Council Of Scientific And Industrial Research |
Process for preparing enantiomerically pure (S)-3-hydroxy-gamma-butyrolactone
|
US7109217B2
(en)
*
|
2002-11-12 |
2006-09-19 |
Merck & Co., Inc. |
Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
|
WO2004050609A1
(en)
*
|
2002-11-27 |
2004-06-17 |
Elan Pharmaceutical, Inc. |
Substituted ureas and carbamates
|
US7470724B2
(en)
*
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7300924B2
(en)
*
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
US7417055B2
(en)
|
2003-04-25 |
2008-08-26 |
Gilead Sciences, Inc. |
Kinase inhibitory phosphonate analogs
|
US7407965B2
(en)
*
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
US7432261B2
(en)
*
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
WO2005002626A2
(en)
*
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US20090247488A1
(en)
*
|
2003-04-25 |
2009-10-01 |
Carina Cannizzaro |
Anti-inflammatory phosphonate compounds
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
US20050261237A1
(en)
*
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
WO2004096287A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
DK1628685T3
(da)
*
|
2003-04-25 |
2011-03-21 |
Gilead Sciences Inc |
Antivirale phosphonatanaloge
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
CN100432038C
(zh)
*
|
2003-09-19 |
2008-11-12 |
宇部兴产株式会社 |
腈化合物、羧酸化合物或羧酸酯化合物的制备方法
|
EP1671937A4
(en)
*
|
2003-09-19 |
2007-08-08 |
Ube Industries |
METHOD FOR PRODUCING A NITRILE COMPOUND, CARBOXYLIC COMPOUND OR CARBOXYLATE COMPOUND
|
US7432273B2
(en)
*
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
US7427624B2
(en)
*
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
US20050131042A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Flentge Charles A. |
HIV protease inhibiting compounds
|
US8193227B2
(en)
|
2003-12-11 |
2012-06-05 |
Abbott Laboratories |
HIV protease inhibiting compounds
|
US20050153990A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Watkins William J. |
Phosphonate substituted kinase inhibitors
|
BRPI0418031A
(pt)
*
|
2003-12-22 |
2007-04-17 |
Gilead Sciences Inc |
inibidores de quinase fosfonato-substituìdos
|
DE602004019815D1
(de)
*
|
2003-12-22 |
2009-04-16 |
Gilead Sciences Inc |
4'-substituierte carbovir- und abacavir-derivate sowie verwandte verbindungen mit hiv- und hcv-antiviraler wirkung
|
ME01059B
(me)
|
2003-12-23 |
2012-10-20 |
Janssen Sciences Ireland Uc |
Proces za pripremanje (3r,3as,6ar)-heksahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (izobutil) amino]-1-benzil-2- hidroksipropilkarbamata
|
US7200207B2
(en)
*
|
2004-03-13 |
2007-04-03 |
Intrado Inc. |
Communication network for providing emergency services
|
HRP20110527T1
(hr)
|
2004-07-27 |
2011-08-31 |
Gilead Sciences |
Nukleozid-fosfonatni konjugati kao sredstva protiv hiv-a
|
US20060116397A1
(en)
*
|
2004-10-13 |
2006-06-01 |
The Trustees Of The University Of Pennsylvania |
Use of saquinavir as a radiation sensitizer
|
US20060135510A1
(en)
*
|
2004-10-13 |
2006-06-22 |
The Trustees Of The University Of Pennsylvania |
Use of amprenavir as a radiation sensitizer
|
JP2008521862A
(ja)
|
2004-12-01 |
2008-06-26 |
デブジェン エヌブイ |
イオンチャンネル、特にkvファミリーのイオンチャンネルと相互作用する5−カルボキサミド置換チアゾール誘導体
|
EP1969940A3
(en)
*
|
2004-12-17 |
2008-12-10 |
Devgen NV |
Nematicidal compositions
|
US20080194554A1
(en)
*
|
2005-03-11 |
2008-08-14 |
Mclean Ed W |
Hiv Protease Inhibitors
|
US20080009517A1
(en)
*
|
2005-10-13 |
2008-01-10 |
The Trustees Of The University Of Pennsylvania |
Use of nelfinavir as a radiation sensitizer
|
HUE026820T2
(en)
*
|
2006-05-09 |
2016-07-28 |
Novaremed Ltd |
The use of Syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
|
CN101631568B
(zh)
|
2007-03-12 |
2012-08-22 |
尼克塔治疗公司 |
低聚物-蛋白酶抑制剂偶联物
|
AU2008244306A1
(en)
|
2007-04-27 |
2008-11-06 |
Tibotec Pharmaceuticals Ltd. |
Methods for the preparation of N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
|
US20090075942A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fosamprenavir
|
GB2452952A
(en)
*
|
2007-09-20 |
2009-03-25 |
Npil Pharmaceuticals |
N-[2-Hydroxy-3-(hydroxycarbonylamino)-3-methyl]-N-methyl-sulphonamide derivatives via N-[2-oxo-3-(hydroxycarbonylamino)-3-methyl]-N-methyl-imine skeleton
|
US20100093811A1
(en)
*
|
2007-09-25 |
2010-04-15 |
Coburn Craig A |
Hiv protease inhibitors
|
GB0804213D0
(en)
*
|
2008-03-06 |
2008-04-16 |
New Era Biotech Ltd |
A method of printing or preventing pain
|
WO2009114151A1
(en)
*
|
2008-03-12 |
2009-09-17 |
Nektar Therapeutics |
Oligomer-amino acid and olgomer-atazanavir conjugates
|
EP2116236A1
(en)
|
2008-04-21 |
2009-11-11 |
Université de Mons-Hainaut |
Bisbenzamidine derivatives for use as antioxidant
|
CA2726610C
(en)
*
|
2008-06-05 |
2015-05-05 |
Asahi Kasei Pharma Corporation |
Sulfonamide compounds and use thereof
|
WO2010002994A1
(en)
|
2008-07-01 |
2010-01-07 |
Purdue Research Foundation |
Nonpeptide hiv-1 protease inhibitors
|
NZ590075A
(en)
*
|
2008-07-08 |
2012-12-21 |
Gilead Sciences Inc |
citrate, malonate and succinate salts of the HIV inhibitor ethyl N-[(S)({ [(2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl]oxy} methyl)phenoxyphosphinoyl]-L-alaninate
|
US8497383B2
(en)
|
2009-05-27 |
2013-07-30 |
Merck Sharp & Dohme Corp. |
HIV protease inhibitors
|
JP2012530069A
(ja)
|
2009-06-12 |
2012-11-29 |
ネクター セラピューティックス |
プロテアーゼ阻害剤、水溶性非ペプチドオリゴマーおよび親油性部分を含む共有結合体
|
US8802734B2
(en)
*
|
2009-09-09 |
2014-08-12 |
Novaremed Limited |
Method of treating or preventing pain
|
WO2011061590A1
(en)
|
2009-11-17 |
2011-05-26 |
Hetero Research Foundation |
Novel carboxamide derivatives as hiv inhibitors
|
DE102010004957A1
(de)
|
2010-01-14 |
2011-07-21 |
Universitätsklinikum Jena, 07743 |
Biologisch wirksame Moleküle zur Beeinflussung von Virus-, Bakterien-, Parasiten-infizierten Zellen und/oder Tumorzellen und Verfahren zu deren Anwendung
|
EP2533793B1
(en)
|
2010-02-12 |
2015-12-09 |
Emory University |
GAL-4 for use in the treatment of infectious diseases
|
CA2791338C
(en)
|
2010-03-02 |
2019-06-11 |
Amakem Nv |
Heterocyclic amides as rock inhibitors
|
CN102190638A
(zh)
*
|
2010-03-16 |
2011-09-21 |
中国科学院上海药物研究所 |
联芳基醇二胺类化合物、其药物组合物、制备方法及应用
|
CN114010776A
(zh)
|
2010-06-09 |
2022-02-08 |
疫苗技术股份有限公司 |
用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
|
CA2803697A1
(en)
|
2010-06-25 |
2011-12-29 |
Facultes Universitaires Notre Dame De La Paix |
Beta carboline derivatives useful in the treatment of proliferative disorders
|
US8785648B1
(en)
|
2010-08-10 |
2014-07-22 |
The Regents Of The University Of California |
PKC-epsilon inhibitors
|
EP2605804B1
(en)
|
2010-08-18 |
2017-03-15 |
Emory University |
Compounds and compositions for ossification and methods related thereto
|
WO2012022780A1
(en)
|
2010-08-19 |
2012-02-23 |
Université Libre de Bruxelles |
18-beta-glycyrrhetinic acid derivatives with anti-tumor activity
|
EP2614055A2
(en)
*
|
2010-09-10 |
2013-07-17 |
Lupin Limited |
Process for preparation of substantially pure fosamprenavir calcium and its intermediates
|
US9079834B2
(en)
|
2010-10-28 |
2015-07-14 |
Merck Canada Inc. |
HIV protease inhibitors
|
US9868728B2
(en)
|
2010-10-29 |
2018-01-16 |
Emory University |
Quinazoline derivatives, compositions, and uses related thereto
|
GB201019043D0
(en)
|
2010-11-10 |
2010-12-22 |
Protea Biopharma N V |
Use of 2',5'-oligoadenylate derivative compounds
|
AU2011336397B2
(en)
|
2010-12-03 |
2016-12-15 |
Emory University |
Chemokine CXCR4 receptor modulators and uses related thereto
|
CN102584748B
(zh)
*
|
2011-01-13 |
2015-02-11 |
浙江九洲药业股份有限公司 |
夫沙那韦中间体的制备方法
|
US8691777B2
(en)
|
2011-01-27 |
2014-04-08 |
Emory University |
Combination therapy
|
CA2826773C
(en)
|
2011-02-24 |
2019-07-16 |
Emory University |
Jab1 blocking compositions for ossification and methods related thereto
|
CA2827392A1
(en)
|
2011-02-24 |
2012-08-30 |
Emory University |
Noggin blocking compositions for ossification and methods related thereto
|
US9365523B2
(en)
|
2011-03-31 |
2016-06-14 |
Emory University |
Imidazolyl amide compounds and uses related thereto
|
WO2012145234A2
(en)
|
2011-04-21 |
2012-10-26 |
Emory University |
Cyclopropyl derivatives and methods of use
|
GB201107223D0
(en)
|
2011-04-29 |
2011-06-15 |
Amakem Nv |
Novel rock inhibitors
|
AU2012252433A1
(en)
|
2011-05-09 |
2013-11-07 |
Universiteit Antwerpen |
Activity-based probes for the urokinase plasminogen activator
|
GB201108225D0
(en)
|
2011-05-17 |
2011-06-29 |
Amakem Nv |
Novel KBC inhibitors
|
CA2839956A1
(en)
|
2011-06-20 |
2012-12-27 |
Emory University |
Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
|
WO2013011485A1
(en)
|
2011-07-20 |
2013-01-24 |
Ranbaxy Laboratories Limited |
Process for the preparation of sulfonamides useful as retroviral protease inhibitors
|
GB201113689D0
(en)
|
2011-08-09 |
2011-09-21 |
Amakem Nv |
Novel PDE4 inhibitors
|
CA2848726C
(en)
|
2011-08-19 |
2019-09-10 |
Emory University |
Bax agonist, compositions, and methods related thereto
|
GB201114854D0
(en)
|
2011-08-29 |
2011-10-12 |
Amakem Nv |
Novel rock inhibitors
|
EP2751079A1
(en)
|
2011-08-31 |
2014-07-09 |
Amakem NV |
Biphenylcarboxamides as rock kinase inhibitors
|
HUE027318T2
(en)
|
2011-09-30 |
2016-10-28 |
Oncodesign Sa |
Macrocyclic FLT3 kinase inhibitors
|
CA2850350A1
(en)
|
2011-09-30 |
2013-04-04 |
Ipsen Pharma S.A.S. |
Macrocyclic lrrk2 kinase inhibitors
|
US9133157B2
(en)
|
2011-10-26 |
2015-09-15 |
Merck Canada Inc. |
HIV protease inhibitors
|
GB201119358D0
(en)
|
2011-11-10 |
2011-12-21 |
Lewi Paulus J |
Disubstituted triazine dimers for treatment and/or prevention of infectious diseases
|
WO2013113722A1
(en)
|
2012-01-30 |
2013-08-08 |
Universiteit Gent |
Anti-invasive compounds
|
GB201204756D0
(en)
|
2012-03-19 |
2012-05-02 |
Lewi Paulus J |
Triazines with suitable spacers for treatment and/or prevention of HIV infections
|
US20150110723A1
(en)
|
2012-05-31 |
2015-04-23 |
Emory University |
Quinazoline derivatives, compositions, and uses related thereto
|
CN104487429B
(zh)
|
2012-07-27 |
2017-07-14 |
爱默蕾大学 |
杂环黄酮衍生物、组合物及与其相关的方法
|
WO2014043019A1
(en)
|
2012-09-11 |
2014-03-20 |
Merck Sharp & Dohme Corp. |
Hiv protease inhibitors
|
WO2014059034A2
(en)
|
2012-10-09 |
2014-04-17 |
President And Fellows Of Harvard College |
Nad biosynthesis and precursors for the treatment and prevention of cancer and proliferation
|
EP2912047B1
(en)
|
2012-10-29 |
2016-08-24 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
JP6479670B2
(ja)
|
2012-11-05 |
2019-03-06 |
エモリー ユニバーシティー |
7,8−ジヒドロキシフラボンおよび7,8−置換フラボン誘導体、組成物、およびそれらに関連する方法
|
WO2014072419A1
(en)
|
2012-11-08 |
2014-05-15 |
Universiteit Antwerpen |
Novel anti-hiv compounds
|
MX367818B
(es)
|
2013-01-29 |
2019-09-09 |
Redx Pharma Plc |
Derivados de piridina como inhibidores de serina/treonina rock y uso de los mismos en el tratamiento de enfermedades autoinmunitarias, inflamatorias, cardiovasculares, etc.
|
BR112015022650A8
(pt)
|
2013-03-15 |
2018-01-23 |
Oncodesign Sa |
inibidores de quinase induzível por sal macrocíclico.
|
WO2015013835A1
(en)
|
2013-07-31 |
2015-02-05 |
Merck Sharp & Dohme Corp. |
Piperazine derivatives as hiv protease inhibitors
|
EP3043803B1
(en)
|
2013-09-11 |
2022-04-27 |
Emory University |
Nucleotide and nucleoside compositions and their uses
|
WO2015055796A1
(en)
|
2013-10-16 |
2015-04-23 |
Université Libre de Bruxelles |
Formulations useful in the treatment of proliferative diseases affecting the respiratory tract
|
NO3068888T3
(en:Method)
|
2013-11-12 |
2018-06-30 |
|
|
US9834526B2
(en)
|
2013-12-19 |
2017-12-05 |
Merck Sharp & Dohme Corp. |
HIV protease inhibitors
|
EP3113780B1
(en)
|
2014-03-06 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Hiv protease inhibitors
|
AU2015239108A1
(en)
|
2014-04-01 |
2016-10-20 |
Institut Jules Bordet |
New strategies for treating melanoma
|
WO2015150337A1
(en)
|
2014-04-01 |
2015-10-08 |
Amakem Nv |
Lim kinase inhibitors
|
US9980936B2
(en)
|
2014-05-05 |
2018-05-29 |
Emory University |
BH4 antagonists and methods related thereto
|
WO2015175855A1
(en)
|
2014-05-16 |
2015-11-19 |
Emory University |
Chemokine cxcr4 and ccr5 receptor modulators and used related thereto
|
EP3180003B1
(en)
|
2014-07-01 |
2022-01-12 |
The Regents of the University of California |
Pkc-epsilon inhibitors
|
US10023602B2
(en)
|
2014-07-08 |
2018-07-17 |
Universiteit Gent |
Hamamelitannin analogues and uses thereof
|
TR201904514T4
(tr)
|
2014-09-17 |
2019-04-22 |
Oncodesign Sa |
Makrosiklik LRRK2 kinaz inhibitörleri.
|
LT3194407T
(lt)
|
2014-09-17 |
2020-01-27 |
Oncodesign S.A. |
Makrocikliniai rip2 kinazės inhibitoriai
|
EP3212196A4
(en)
|
2014-10-29 |
2018-07-11 |
Wisconsin Alumni Research Foundation |
Boronic acid inhibitors of hiv protease
|
WO2016083490A1
(en)
|
2014-11-27 |
2016-06-02 |
Remynd Nv |
Compounds for the treatment of amyloid-associated diseases
|
JP6735751B2
(ja)
|
2014-12-15 |
2020-08-05 |
エモリー ユニバーシティー |
B型肝炎ウイルスの治療のためのホスホルアミデート
|
KR20230130175A
(ko)
|
2014-12-26 |
2023-09-11 |
에모리 유니버시티 |
N4-하이드록시시티딘, 이와 관련된 유도체 및 이의 항 바이러스적 용도
|
WO2016146651A1
(en)
|
2015-03-16 |
2016-09-22 |
Oncodesign Sa |
Macrocyclic activin-like receptor kinase inhibitors
|
CA2984379C
(en)
|
2015-04-28 |
2024-06-11 |
Newsouth Innovations Pty Limited |
Targeting nad+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies, and inactivity
|
EP3302455B1
(en)
|
2015-05-29 |
2020-09-16 |
Emory University |
2-amino-n'-benzylideneacetohydrazides and derivatives for the management of cftr protein mediated diseases
|
JP6913101B2
(ja)
|
2016-02-29 |
2021-08-04 |
オンコデザイン エス.ア. |
放射性標識大環状egfr阻害剤
|
WO2017157882A1
(en)
|
2016-03-14 |
2017-09-21 |
Université Catholique de Louvain |
Serine biosynthetic pathway inhibitors
|
CN109689063A
(zh)
|
2016-04-28 |
2019-04-26 |
埃默里大学 |
含有炔烃的核苷酸和核苷治疗组合物及其相关用途
|
EP3458072B1
(en)
|
2016-05-19 |
2020-09-30 |
Universiteit Antwerpen |
Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases
|
BE1023757B1
(nl)
|
2016-06-30 |
2017-07-12 |
Yun NV |
Bewaring van micro-organismen
|
WO2018065387A1
(en)
|
2016-10-04 |
2018-04-12 |
Universiteit Gent |
Novel hamamelitannin analogues and uses thereof
|
CN109923123B
(zh)
|
2016-10-14 |
2024-01-23 |
爱默蕾大学 |
具有结合或阻断pd-l1的分子的纳米颗粒及其在治疗癌症中的用途
|
CN110049866B
(zh)
|
2016-10-26 |
2022-04-05 |
爱默蕾大学 |
多金属氧酸盐络合物在制备用于治疗癌症的药物组合物中的用途以及该药物组合物
|
US10738002B2
(en)
|
2016-11-24 |
2020-08-11 |
Universitair Ziekenhuis Antwerpen |
Halogenated benzotropolones as ATG4B inhibitors
|
WO2018111580A1
(en)
|
2016-12-13 |
2018-06-21 |
Emory University |
Polypeptides for managing viral infections
|
US20190388426A1
(en)
|
2017-01-30 |
2019-12-26 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
IL309069A
(en)
|
2017-02-21 |
2024-02-01 |
Univ Emory |
CXCR4 cytokine receptor modulators and related uses
|
EP3634407A1
(en)
|
2017-05-11 |
2020-04-15 |
Remynd N.V. |
Inhibitors of pde6delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disorders
|
WO2018206760A1
(en)
|
2017-05-11 |
2018-11-15 |
Remynd N.V. |
Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders
|
ES2969496T3
(es)
|
2017-08-01 |
2024-05-20 |
Gilead Sciences Inc |
Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2- il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
|
AU2018367909B2
(en)
|
2017-11-17 |
2022-03-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of eye disorders
|
HRP20241620T1
(hr)
|
2017-12-07 |
2025-01-31 |
Emory University |
N4-hidroksi-citidin i derivati i antivirusna uporaba s njima povezana
|
WO2019193091A1
(en)
|
2018-04-05 |
2019-10-10 |
Universiteit Hasselt |
Selective pde4d inhibitors against demyelinating diseases
|
PL3813882T4
(pl)
|
2018-06-29 |
2024-04-08 |
Rejuvenate Biomed |
Kombinacja farmaceutyczna zawierająca biguanid i inhibitor acetylocholinoesterazy do stosowania w chorobach związanych z wiekiem i/lub chorobach zwyrodnieniowych
|
US11987589B2
(en)
|
2018-08-07 |
2024-05-21 |
Emory University |
Heterocyclic flavone derivatives, compositions, and methods related thereto
|
US12281308B2
(en)
|
2018-08-29 |
2025-04-22 |
University Of Massachusetts |
Inhibition of protein kinases to treat Friedreich ataxia
|
US12240829B2
(en)
|
2019-03-20 |
2025-03-04 |
Emory University |
Prostaglandin receptor EP2 antagonists, derivatives, and uses related thereto
|
WO2020229595A1
(en)
|
2019-05-14 |
2020-11-19 |
Molecular Targeted Radiopharmaceuticals Holding Gmbh (Mtr) |
Quinazoline-2,4-dione derivatives as parp inhibitors
|
AU2021225333A1
(en)
|
2020-02-24 |
2022-08-11 |
Katholieke Universiteit Leuven |
Pyrrolopyridine and imidazopyridine antiviral compounds
|
GB202003240D0
(en)
|
2020-03-05 |
2020-04-22 |
Ecosynth Nv |
Antiviral treatment
|
US20230158178A1
(en)
|
2020-03-16 |
2023-05-25 |
Emory University |
Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof
|
WO2021209563A1
(en)
|
2020-04-16 |
2021-10-21 |
Som Innovation Biotech, S.A. |
Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
|
US12083099B2
(en)
|
2020-10-28 |
2024-09-10 |
Accencio LLC |
Methods of treating symptoms of coronavirus infection with viral protease inhibitors
|
WO2022157381A1
(en)
|
2021-01-25 |
2022-07-28 |
Universiteit Hasselt |
Phloretin for use in the treatment of neurodegenerative and demyelinating diseases
|
EP4377307A1
(en)
|
2021-07-30 |
2024-06-05 |
Confo Therapeutics N.V. |
Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
|
WO2023021132A1
(en)
|
2021-08-18 |
2023-02-23 |
Katholieke Universiteit Leuven |
6-substituted- and 6,7-disubstituted-7-deazapurine ribonucleoside analogues
|
WO2023046900A1
(en)
|
2021-09-23 |
2023-03-30 |
Katholieke Universiteit Leuven |
Ribonucleoside analogues against -sars-cov-2
|
WO2023105283A1
(en)
|
2021-12-08 |
2023-06-15 |
Fundacio Privada Institut De Recerca De La Sida - Caixa |
Nucleoside reverse transcriptase inhibitors for use in down syndrome and alzheimer`s disease therapy
|
US11541071B1
(en)
|
2021-12-16 |
2023-01-03 |
Ascletis BioScience Co., Ltd |
Nucleoside derivatives and methods of use thereof
|
WO2023111683A1
(en)
|
2021-12-16 |
2023-06-22 |
Ascletis Bioscience Co., Ltd. |
N4-hydroxycytidine derivatives and use thereof as antiviral agent
|
US11760722B2
(en)
|
2022-01-18 |
2023-09-19 |
Ascletis Bioscience Co., Ltd. |
Inhibitors of cysteine proteases and methods of use thereof
|
WO2023139402A1
(en)
|
2022-01-18 |
2023-07-27 |
Ascletis Bioscience Co., Ltd. |
Inhibitors of cysteine proteases and methods of use thereof
|
WO2023180567A1
(en)
|
2022-03-24 |
2023-09-28 |
Fundacion Privada Institut De Recerca De La Sida-Caixa |
Cyclodextrins for use in coronavirus infection therapy
|
WO2023241799A1
(en)
|
2022-06-15 |
2023-12-21 |
Université Libre de Bruxelles |
Flavanols for use in the treatment of retroviral infections
|
US20240025885A1
(en)
|
2022-07-08 |
2024-01-25 |
Ascletis BioScience Co., Ltd |
Triazine derivatives and methods of use thereof
|
CN115504968B
(zh)
|
2022-11-21 |
2023-04-18 |
歌礼生物科技(杭州)有限公司 |
三嗪衍生物
|
WO2024193451A1
(en)
|
2023-03-17 |
2024-09-26 |
Ascletis BioScience Co., Ltd |
Triazine derivatives, method of making and method of using thereof
|
WO2025104221A1
(en)
|
2023-11-15 |
2025-05-22 |
Université Libre de Bruxelles |
Uses of protein tyrosine phosphatase receptor kappa inhibitors
|